Targeting, Affinity Labeling
Small-molecule Polyethylene Glycol
Over 4,000 high-purity PEG linkers
cGMP-grade PEG products supplied
Custom synthesis services supported
Large inventory ensuring stable supply
ADC linker is the bridge between antibodies and cytotoxic drugs and plays a key role in antibody-drug conjugate (ADC) drugs because its properties greatly affect the therapeutic indicators, efficacy, and pharmacokinetics of these drugs. The ideal conjugation must be stable in vitro or in the blood circulation to prevent systemic toxicity caused by premature release of cytotoxic drugs, while at the same time being able to enter and kill cancer cells through the rapid release of effective cytotoxic drugs. BOC Sciences can provide ADC linkers with multiple cleavage mechanisms according to your project needs, including enzymatic cleavage linkers, chemical cleavage linkers and peptide linkers. We also support the integrated design of linkers to modulate payload release and ADC stability for optimal efficacy of ADC drugs.
Consult with Our Experts
*24/7 customer support, responding within 24 hours of your inquiry.
| Catalog No. | Name | Structure | M.W. | Purity | Buy |
|---|---|---|---|---|---|
| BPG-1890 | Hexaethylene glycol |
|
≥95% | ||
| BPG-1815 | HO-PEG5-OH |
|
≥95% |
Background
What is Small-molecule Polyethylene Glycol?
Small-molecule polyethylene glycol (PEG) refers to PEG compounds with low molecular weights (typically below 10,000 Da). When used as small molecules, PEGs can offer unique advantages in different fields, and can be used to modify various types of biological drugs, forming formulation materials through positively ionized lipophilic liposome nanoparticles, which will make it possible to instantly load targeted molecules and achieve mounting of any drug, and can provide proven technical support for building personalized therapeutic drug libraries for oncology patients.
Fig. 1. Structure of poly(ethylene glycol) (Theranostics. 10(7): 3064-3082).
Examples of Small Molecule Polyethylene Glycols
HO-PEG5-OH
HO-PEG5-OH is a small molecule PEG with 5 glycol units, which can be used as versatile polymer chain segments for modulating the solubility, stability, and bioavailability of drugs, or as plasticizers, lubricants, or modifiers of materials.
Hexaethylene Glycol
Hexaethylene glycol is part of jasmine leaf extract and has antioxidant, antibacterial and anticancer properties. It also shows potential application as a functional hydraulic fluid.
Dodecaethylene Glycol
Dodecaethylene glycol has a long glycol chain containing 12 glycol units. It can be used in the preparation of certain surfactants, colloidal systems and drug delivery systems, among others.
Modification of Small Molecule PEG
Depending on the nature of the reaction between the modifier and the modified compound, the modification reaction is mainly classified into the types of acylation reaction, alkylation reaction, redox reaction, aromatic ring substitution reaction, etc., which chemically modifies the modified compound with the side-chain groups such as amino group, sulfhydryl group and carboxyl group. Depending on the molecular weight, molecular structure, and physical and chemical properties of the modified compounds, including proteins, peptides, monoclonal antibody molecular fragments, and small molecule compounds, different PEGylation techniques are used to modify these compounds.
How to Activate Small Molecule PEG?
The connection between small molecule PEG and other compounds is mainly through the terminal hydroxyl group of PEG, such as amino acid residues. However, the terminal hydroxyl group of PEG is very inactive and it is difficult to couple with other groups in a mild environment, so an activator is needed to activate the hydroxyl group. Activated PEG can covalently modify the modified substance in a mild environment. Methods of activation include: cyanogen bromide method, carbonyl diimidazole method, cyanuric chloride method, and PEG structure modification method.
Application of Small Molecule PEG
- Protein Precipitation: By adding appropriate amount of PEG (PEGylation of Proteins) and salt to the solution, the protein can be precipitated, thus realizing the separation and enrichment of protein.
- Cell Fusion: By adding PEG to two cell populations, cells can be induced to fuse and form hybrid cells. This is useful in areas such as cell research, antibody production and bioengineering.
- DNA or RNA Precipitation: By adding PEG to a DNA or RNA solution (PEGylation of Nucleic Acids), nucleic acids can be precipitated out, thereby removing impurities and purifying the target molecule.
- Protein Crystallization: The use of small molecule PEGs as co-solvents can provide the right solution conditions to facilitate protein crystallization and improve the quality and growth rate of crystals.
- Cell Protection and Freezing: Small molecule PEG has the ability to protect cells from damage during freezing and thawing. Mixing cells with appropriate concentrations of PEG during cell cryopreservation provides osmotic protection and reduces freezing-induced cell damage.
- Stabilizers for Antibodies and Enzymes: Small molecule PEG can be used as stabilizers for antibodies and enzymes, prolonging their activity during storage and use.
BOC Sciences provides high quality small molecule PEG products based on expertise and experience, if you are interested in our products, please feel free to contact us.
Reference
- Wu, D. et al. An EPR Strategy for Bio-responsive Fluorescence Guided Surgery with Simulation of the Benefit for Imaging. Theranostics. 10(7): 3064-3082.
Planning to purchase or looking for custom solutions?
Get in touch with our experts today! We'll respond within 24 hours to discuss your project needs and provide a customized quote.
You May Also Be Interested In
From custom PEG synthesis to PEGylation support, explore tailored services designed to meet the specific needs of your research.
Gain Deeper Insights
Browse related content to gain a deeper understanding of PEG synthesis and manufacturing.
PEG and PEG Derivatives
-
-
Imaging, Tracer Conjugation
-
Controlled Synthesis, Protection
-
Crosslinking, Selective Conjugation
-
Protein Crosslinking, Stabilization
-
Liposome, Drug Delivery
-
Stealth, Drug Solubilization
-
Precise Conjugation, Uniformity
-
Drug Conjugates, Scaffolds
-
Branched Polymers, Multifunctionality
Clients Who Choose BOC Sciences
Testimonials from Our Global Research Partners
Your Trusted Source for High-Quality Products and Scientific Services.
"BOC Sciences supported our lipid impurity reference standard project with excellent technical insight. The custom synthesis was completed faster than expected, and the analytical data package was very thorough. Communication was clear and efficient throughout the project."
Dr. Michael Turner
Senior Analytical Scientist (United Kingdom)
"We needed a custom ionizable lipid for formulation screening, and BOC Sciences handled both the synthesis and scale-up smoothly. The material quality was consistent batch to batch, which saved us a lot of development time."
Ms. Emily Rodriguez
Formulation Development Lead (United States)
"Our project involved a structurally complex PEGylated lipid that required careful process optimization. BOC Sciences provided practical solutions and delivered a high-purity product that met all our specifications."
Dr. Thomas Weber
Process Development Scientist (Germany)
"BOC Sciences has been a reliable partner for our custom lipid synthesis needs. Their team understands both research and preclinical requirements, and the documentation they provided was clear and well organized."
Ms. Laura Bennett
CMC Project Manager (Canada)
"We were impressed by how efficiently BOC Sciences handled a challenging scale-up of a specialty phospholipid. The timelines were respected, and the technical support during the process was very professional."
Dr. Nicolas Martin
Senior Research Chemist (France)
"For a time-sensitive formulation study, we needed a non-standard lipid with tight purity specifications. BOC Sciences delivered exactly what we needed and kept us updated at every key milestone."
Mr. Daniel Foster
R&D Program Manager (United States)
